EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters
The European Commission is considering emergency approvals for CO read more.....»»
Can I Be Required to Get Vaccinated Against Covid-19?
The U.S. Covid-19 vaccine rollout reached another milestone in early May when Pfizer Inc. and BioNTech SE, makers of the first inoculation authorized for emergency use in the country, asked for full regulatory approval. Such a designation for .....»»
: Fauci says U.S. may not even need AstraZeneca’s COVID-19 vaccine: report
AstraZeneca PLC's COVID-19 vaccine, which has been plagued by problems with its rollout, may not even be needed in the U.S., Dr. Anthony Fauci told Reuters......»»
State widens Covid vaccine eligibility, announces public-private partnership to boost distribution
Gov. Jay Inslee announced Monday a public-private partnership to move the state's Covid-19 vaccination efforts forward, effective immediately. The state has moved to the next phase of its rollout, Phase 1B. The first tier of Phase 1B will now extend.....»»
An employer’s dilemma: to mandate (or not) the Covid-19 vaccine?
During a year in need of some brightness, December brought some great news: after emergency Food and Drug Administration approvals, first Pfizer and then Moderna shipped Covid-19 vaccines to locations throughout the United States, kicking off a ma.....»»
Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September (JNJ)
Reuters Johnson & Johnson announced Monday that it identified a lead COVID-19 vaccine candidate that could begin human trials in September and be ready for emergency authorization use in 2021. Shares of the healthcare com.....»»
An Ohio state representative is trying to block the state"s $5 million vaccine lottery
Ohio Rep. Jena Powell told CNN's "New Day" on Monday that the COVID-19 vaccine lottery is a "gross misuse of taxpayer dollars." Dado Ruvic/Reuters An Ohio state lawmaker says she'll try to block the state's vaccine lottery.....»»
Pfizer Hits Deadlock With India Over Vaccine Indemnity Issue: Reuters
Pfizer Inc (NYSE: PFE) and the Indian government are at loggerheads over a demand by the company for legal protection from any claims linked to the use of its COVID-19 vaccine, said read more.....»»
AstraZeneca"s COVID vaccine Vaxzevria authorized for emergency use in Japan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A pediatric infectious disease expert answers 7 common questions about children getting the COVID-19 vaccine
The FDA expanded emergency use of the Pfizer-BioNTech vaccine to children aged 12 to 15 on May 10, and so far no severe reactions have been reported. Charles Muro, age 13, celebrates being ino.....»»
G20 Countries Water Down US Push For COVID-19 IP Waiver: Reuters
G20, a global forum representing the world’s largest economies, has come forward supporting “voluntary licensing” of COVID-19 vaccine patents, the draft conclusions of a summit shows. read more.....»»
: Swimsuits and luggage are hot items as U.S. shoppers prepare for summer events with relaxed COVID restrictions
Retailers are highlighting the categories that are on the upswing as the vaccine rollout continues and stimulus cash drives sales......»»
Japan’s economy slumps back into decline as COVID-19 hits spending
Japan’s economy shrank more than expected in the first quarter as a slow vaccine rollout and new COVID-19 infections hit spending on items such as dining out and clothes, raising concerns the country will lag others emerging from the pandemic......»»
Competing for tech talent? Give people the chance to change the world while advancing their careers
The talent crisis is poised for a comeback. The economic consequences of Covid-19 wiped out previously low unemployment rates in 2020, making it an employer’s market for many industries. As the vaccine rollout continues and the economy r.....»»
European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: Reuters
read more.....»»
Novavax extends 2-day loss to 31% as the biotech firm delays seeking emergency authorization for its COVID-19 vaccine
"We know that we are delaye.....»»
The NHS is launching a "vaccine passport" on its app for international travel
Downing Street said the NHS app's COVID-19 "vaccine passport" tool would be ready on Monday, when the UK's ban on international travel is lifted. Dado Ruvic/Reuters The UK's National Health Service app will be available on Monday to use.....»»
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15
The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. read more.....»»
FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15
The U.S. Food and Drug Administration late Monday authorized the emergency use of Pfizer Inc. and BioNTech SE COVID-19 vacccine for children between the age.....»»
Why Novavax Shares Are Trading Lower Today
Novavax (NASDAQ: NVAX) shares are trading lower amid reports competing COVID-19 vaccines may be approved in Europe. The stock also dipped on reports the company is unlikely to seek emergency use authorization for its COVID-19 vaccine until June. read more.....»»
Eli Lilly to boost supply of Covid treatment in India, Reuters reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»